Abstract
Background
Alternative options to hospital care like home care or local health centers (LHCs) are being advocated. However, no study has measured citizens’ preferences (who will finance these services via taxation) for these options.
Objectives
We measured (i) citizens’ preferences for these services, that is, respondents stated where they would like to get the treatment; (ii) the strength of their preference.
Methods
A computerized survey composed of (i) a decision aid to inform respondents about the three options; (ii) three scenarios, from light-to-heavy care, that respondents should rank from the most to the least preferred option of care. (iii) a contingent valuation survey (CVS) to assess how much respondents were willing to pay for their preferred option (except for hospital care if chosen, because it is the default option and free). (iv) a socio-demographic questionnaire.
Results
Data were collected from a representative sample of citizens living in the Rhône–Alps Region (n = 800). The heavier the care was, the more respondents preferred hospital care. Willingness to pay for additional taxation per household/month varied from €13.9 for light care in LHC to €19.1 for heavy home care. The small number of protesting respondents and outliers, and the close correlation between preferences, income, and WTP supports the validity of the CVS.
Conclusion
In France, for cancer, not all citizens would prefer to be treated at home rather than in a hospital. Only less than a quarter would prefer LHC. These results show the mismatch between public health policies and the citizens’ preferences.
Key words: contingent valuation, willingness to pay, home care, preference, cancer, hospital, public decision-making
Introduction
Cancer is one of the leading causes of death and disability worldwide (1). Cancer treatment has received additional attention in the last decade because of the very high costs associated with new targeted therapies (type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread, for example, bevacizumab an angiogenesis inhibitors nivolumab, anti-PD1 antibody). In France like in many other developed countries (England, Japan, Canada, Australia, Spain, Denmark), (2–4) the debate has also focused on where patients should receive and would prefer to receive their treatment, that is, in hospital, home or in local health centers (LHC) (2;5;6).
A large variety of treatments can now be provided at home (e.g., antibiotics, parenteral feeding, pain treatments, dressing changes, chemotherapy, and palliative care), 24 h a day, 7 days a week through a hotline with the same level of safety and effectiveness as in the hospital (7). However, even though its use is growing, home care is still under-used (8;9) representing less than 0.7 percent of cancer care (2).
LHCs are ambulatory facilities usually run by teams of GPs, nurses, and/or physiotherapists and are found in large cities, suburbs, small towns, and rural areas. The number of LHCs is increasing in France since 2000. However, they do not currently offer cancer treatments, but healthcare decision makers (DMs) think that they represent a potential option for cancer care. They are assumed to have the advantages of safety and effectiveness of treatment and closer proximity to home without the perceived drawbacks of home care (e.g., intrusion of care into daily life) and hospital (e.g., the stress of hospitalization, proximity to other patients).
In response to the increasing demand for care in cancer as well as more generally in chronic care, DM wish to develop these alternative options to hospital care, hoping they could be both cost-saving and preferred by patients. Nonetheless, reality is more complex. A survey showed that cancer patients may prefer hospital as compared to home care, especially for complicated care (8). In this survey, the vast majority of cancer patients in the Rhone–Alps region wanted to separate home life from the place of care and wanted to avoid becoming a burden on their relatives. A quarter of the patients (24 percent) preferred home care mainly to avoid traveling, maintain their lifestyle, and because they found hospitals frightening. Only 5 percent of participants preferred to receive treatment in LHCs. Based on these findings, we wanted to explore French citizens’ preferences for place of care for cancer (i.e., a respondent states where they would like to get the service if needed, between home care, LHC, or hospital in the same region that our survey on patient’s preferences was done (10)) and their strength of preference for their chosen alternative. We decided to study the general public (i.e., citizens) preferences because their preferences matter re what will be funded or not (e.g., via taxation). Indeed, French healthcare system is collectively and publicly funded.
We conducted a willingness to pay (WTP) survey in the Rhone–Alps region of France among the general population on the topic of hospitals versus alternative places of care for cancer. Contrary to other measures of preference, WTP has the advantage to allow capturing the opportunity cost of the type of service chosen if additional resources are required to develop it (11). In other words, it forces the respondent to think where the additional money will come from. It is especially interesting in our context where the development of the alternative places of care will be funded by citizens. To the best of our knowledge, the questions asked in this study have not been studied for hypothetical options related to service use (and not a specific treatment). Also, contingent valuation surveys in healthcare are also typically used to study use value, that is, actual users WTP in a ex post context or at the point of consumption (12). Our goals were twofold:
To elicit from a representative sample of citizens their preferences for the three options: home care, LHC, and hospital.
To conduct a contingent valuation survey among the participants to measure how much they are willing to pay for their preferred option.
The results obtained could help DM to prioritize the alternative places of care that are respectful of the general population’s preferences in the Rhone–Alps Region. The methodology described in this study can help DM in other regions.
Survey design and data collection
Participants
Participants were adults over 18 years old recruited by the national survey institute “Research Now.” Ethics approval for the study was obtained (Leon Bérard cancer center Ethics committee, Advisory Committee on Information Processing in Material Research in the Field of Health).
CV survey
Because clear and understandable information about the options is an important prerequisite for the CV method (13), we decided to integrate a decision aid in our CV survey. Decision aids have been shown to increase patients’ understanding and improve the quality of the information conveyed (14;15). The web CV survey was divided into four sections:
Questionnaires on citizens’ sociodemographic and experience of care. There was also a question on the respondent’s perception of their cancer risk because our hypothesis was that the more the respondent worried about cancer, the higher would be their WTP.
A computerized decision aid that provided information on the three options of care (hospital care, home care, LHC) developed in a previous study of our team (10).
Preference measures for different scenarios of cancer care. To be as realistic as possible in representing the diversity and complexity of the cancer context, we developed three scenarios, in collaboration with clinicians. To validate the scenarios developed, a pre-test was done among a convenient sample of clinicians (n = 6) not involved in the development on the survey, belonging to four different structures managing cancer patients at home or at hospital to test the neutrality of information and the plausibility of the scenarios. The three scenarios are ranging from light (curative) cancer care to heavy (e.g., palliative) care:
Scenario 1: short chemotherapy (<1 h) every month for 6–12 months.
Scenario 2: medium or long chemotherapy (2–6 h) over 5 consecutive days for 6–2 months.
Scenario 3 (e.g., palliative care): patient can have different types of care (chemotherapy, treatment against pain in infusion, an antibiotic in infusion, enteral or parenteral feeding, a blood transfusion) as needed. For each scenario, the respondent had first to rank the options (hospital, home care or LHC) from the most to the least preferred and then to indicate using visual analog scales (VAS) the strength of their preference for their preferred option. To study preference determinants, attitudinal questions related to cancer management were also added. These questions were developed from reasons given by cancer patients to explain their own preferences for a place of care collected in our research team’s previous studies (6;10;16) (Supplementary Material S1).
The CV question: WTP for home care and for LHC. For each scenario, the WTP question was: “How much is the maximum are you willing to pay per month per household to use [the respondent’s preferred option: home care /LHC] if needed? Please bear in mind that your payment would reduce the amount of money you have to pay for other goods/services.” Only respondents who declared they preferred home care or LHC to the hospital were asked to respond to this question. For example, if a respondent preferred home care in scenario 1, LHC in scenario 2 and hospital in scenario 3, two WTP questions were asked, one about home care in scenario 1 and the other one about LHC in scenario 2. If a respondent preferred a hospital for each scenario, no WTP question was asked since in the French healthcare system cancer management in a hospital is considered the default option and provided free of charge, thus the question is irrelevant and can be confusing to respondents.
WTP elicitation format: payment card
The respondents were asked to indicate their maximum WTP using a payment card where payment bids ranged from 0 to 25 Euros, with the possibility of giving another amount. These amounts were determined in a pre-test of the whole survey, which was administrated online to a sample of 100 individuals from the general population (Supplementary Material S2).
“Cheap talk” and follow-up question
To mitigate the divergence between real and hypothetical payments called hypothetical bias (16) a “cheap talk” that is, a statement that emphasizes the importance of the respondent’s answers to incite them to devote more effort, attention, to the preference elicitation task (17–19) has been added. Moreover, after the WTP questions, respondents were asked to indicate in a follow-up question, how sure they were about the amount chosen on a scale from 1 to 10 (where 1 is very uncertain and 10 is very certain).
Payment method
The method of payment can impact the WTP and the proportion of protest zeros (20–22). The choice of payment method has to be realistic and neutral with respect to the context (23). Even if a tax is generally associated with a high rate of protest responses (24), we decided to use it as a payment method because in France more than 75 percent of healthcare spending is publicly funded. Moreover, there were no protest responses about this type of payment method in the pre-test results.
Statistical analysis
There are several ways to estimate mean and median WTP. The first is to consider the selected bid amount on the payment card as an exact expression of the respondent’s maximum WTP (25). The second method is based on the interval regression model which is particularly relevant when the payment card is used. This model is a reparameterization of the random utility model developed by Hanemann (26). The true WTP value is considered to be between the amount selected and the next higher amount on the payment card, that is, the WTP was within this range. The interval regression model can be estimated with the intercept only to estimate the median and the mean WTP for the sample. (27). We used the log of the WTP to produce a near-normal distribution because the WTP values were not normally distributed. Moreover, the estimate with the interval regression model is presented with the non-parametric bootstrap estimate of the 95 percent confidence interval with 1,000 replications. We also estimated separately the WTP in the sub-group of respondents who were sure of their WTP. For the recoding method, the threshold used for considering a response as certain was seven, as recommended by some authors (28;29).
The interval data model has also been used to study the variables affecting the WTP and to test its internal validity. Variables used in the WTP analyses and the associated hypothesis are described in Supplementary Material S3. The models were compared with AIC (i.e., Akaike’s Information Criteria), BIC (i.e., Bayesian Information Criteria) log-likelihood and the Cox–Snell pseudo-R2 in which the ratio of the likelihoods reflects the improvement of the full model over the intercept-only model. The coefficients estimated can be interpreted like in the OLS model: if we change x by 1 (unit), we expect our y variable to change by approximately 100⋅β1 percent. The exact value is: percentΔy = 100×(exp(β1)−1). In addition, two-way ANOVA or mixed model and non-parametric tests had been used to compare continuous variables across groups.
Finally, to classify the protest respondents (i.e., respondents indicating zero WTP for their preferred option) they were asked to explain why they were unwilling to pay by ticking the most important reason from a list of possible explanations provided. According to the literature (30), a zero WTP can be reclassified as a true zero WTP or as a protest response. We classified here a zero value as a protest response if the respondent checked “I did not understand the question”, “There was not enough information for me to choose”, “I refuse to pay for care”, “Other.” After controlling with binary logit regression to ensure that the protest respondents were not different from respondents who provided a positive or a true zero WTP, we excluded the protesters from the analysis of the WTP (Supplementary Material S4).
Results
Sample characteristics
We aimed to recruit a sample that is representative of the population of the Rhone–Alps Region. It was developed with the quota method regarding sex, age, socioprofessional category, and administrative department sub-regions criteria.
A total of 1,046 individuals were invited to participate to the web-based survey and 95.7 percent accepted, corresponding to a sample of 1,001 respondents. We focus here on a random sub-sample of 800 respondents, who responded with a payment card, the other 201 individuals were given an alternative elicitation method for their WTP that we do not present in this paper.
Respondents’ characteristics are presented in Table 1. Respondents were 46 ± 14.7 years old on average. More than a half had a university degree and were fully employed. A quarter had a post-tax net annual household income under €21,000. A large majority, 92.2 percent, had additional private health insurance as well as public health insurance.
Table 1.
General population sample characteristics
| Characteristic (N = 800) | Mean (sd) or n (%) |
|---|---|
| Gender Male | 377 (47.1%) |
| Age years mean (sd) | 46.0 (14.7) |
| Education degree | |
| Primary | 38 (4.8%) |
| Secondary | 310 (38.8%) |
| University | 452 (56.5%) |
| Employed (Yes) | 481 (60.1%) |
| Socio-professional category | |
| High | 238 (29.8%) |
| Low | 260 (32.5%) |
| Inactive/Not employed | 302 (37.8%) |
| Employment status | |
| Full-time | 424 (53.0%) |
| Part-time | 57 (7.1%) |
| Retired | 161 (20.1%) |
| Unemployed | 120 (15.0%) |
| Student | 38 (4.8%) |
| Living with a partner Yes | 569 (71.1%) |
| Children (<18 yr) at home (Yes) | 271 (33.9%) |
| Annual household income | |
| <€21,000 | 204 (25.5%) |
| €21,000–<€36.000 | 243 (30.4%) |
| >€36,000 | 296 (37.0%) |
| Missing | 57 (7.1%) |
| Public health insurance Yes | 129 (16.1%) |
| Private additional health insurance Yes | 738 (92.2%) |
| What is the price of this? (month/person) | |
| <€30 | 125 (16.9%) |
| €30–€50 | 180 (24.4%) |
| €50–€70 | 105 (14.2%) |
| €70€–€100 | 125 (16.9%) |
| >€100 | 115 (15.6%) |
| Do not know | 88 (11.9%) |
| Distance from home to hospital | |
| <5 km | 274 (34.2%) |
| 5–15 km | 280 (35.0%) |
| 15–30 km | 196 (24.5%) |
| >30 km | 50 (6.2%) |
| Do you have a local health centre close to your home? | |
| Yes | 201 (25.1%) |
| No | 189 (23.6%) |
| Do not know | 410 (51.2%) |
| Distance from home to local health centre (n = 200) km | |
| <5 km | 81 (40.3%) |
| 5–15 km | 86 (42.8%) |
| 15–30 km | 25 (12.4%) |
| >30 km | 9 (4.5%) |
| Mental quality of life: sadness during last 2 wk | |
| Not at all | 437 (54.6%) |
| Several days | 267 (33.4%) |
| More than the half of the days | 60 (7.5%) |
| Almost every day | 36 (4.5%) |
| Quality of life on VAS from 0 to 10 mean (sd) | 8.5 (1.7) |
VAS, visual analog scale.
Table 2 shows respondents’ experience of care, 73.1 percent had already been hospitalized and 35.6 percent had already experienced home care. Concerning cancer, 55.1 percent knew a relative who had already had cancer. Only 5.2 percent of the respondents had already been treated for cancer and 1.2 percent were still under treatment.
Table 2.
General population’s experience of care
| n (%) | |
|---|---|
| Personal experience | |
| Hospital | |
| Yes | 585 (73.1) |
| No | 215 (26.9) |
| Hospital with length of stay >5 days | |
| Yes | 358 (61.2) |
| No | 227 (38.8) |
| Cancer | |
| Yes | 42 (5.2) |
| Yes under treatment | 10 (1.2) |
| No | 739 (92.4) |
| I do not wish to answer this question | 9 (1.1) |
| Individual perception of cancer risk at 10 yr | |
| High or very high | 158 (19.8) |
| Moderately high | 251 (31.4) |
| Low or very low | 161 (20.1) |
| Do not know | 230 (28.8) |
| Home care | |
| No | 515 (64.4) |
| Yes | 285 (35.6) |
| Home care for heavy cancer care | |
| No | 790 (98.8) |
| Yes | 10 (1.2) |
| Home care for heavy care | |
| No | 753 (94.1) |
| Yes | 47 (5.9) |
| Local health centre for cancer | |
| No | 796 (99.5) |
| Yes | 4 (0.5) |
| Local health centre for heavy cancer care carescancer | |
| No | 796 (99.5) |
| Yes | 4 (0.5) |
| Respondent’s relatives’ experience | |
| Relatives who have already had cancer | |
| Yes | 441 (55.1) |
| No | 350 (43.8) |
| I do not wish to answer this question | 9 (1.1) |
| Home care for cancer | |
| No | 650 (81.2) |
| Yes | 150 (18.8) |
| Local health centre for cancer | |
| No | 776 (97.0) |
| Yes | 24 (3.0) |
| Home care | |
| No | 391 (48.9) |
| Yes | 409 (51.1) |
Ranking of scenarios
As shown in Figure 1, the preferred option for scenario 1 (light care) was home care for 46.1 percent of the respondents, hospital for 35.1 percent and LHC for 18.7 percent. For medium care, hospital and home care were closely ranked with respectively 37.0 percent and 38.1 percent of respondents choosing these options as the first choice. For heavy care, hospital was the first choice for a large majority of respondents (49.1 percent), followed by home care (29.5 percent). Whatever the scenario, LHC was the option with the lowest proportion of respondents preferring it as a first choice. The strength of preference (measured with VAS from 0 to 10) was significantly higher for respondents who preferred home care (whatever the scenario) (p < .001); scores were 8.5 ± 1.5, 8.4 ± 1.6, 8.3 ± 1.7 for light, medium and heavy care respectively. For hospital, scores were 8.1 ± 1.6, 8.0 ± 1.6, and 8.0 ± 1.6 for light, medium and heavy care respectively; and for LHC, scores were 7.7 ± 1.6, 7.6 ± 1.4, 7.6 ± 1.3 for light, medium and heavy care respectively. LHC was the option with the weakest preferences.
Figure 1.
Diagram of the general population study: whole sample n = 800.
WTP estimations for home care and LHC
Table 3 summarizes the results for the WTP questions. These results demonstrate that there are significant differences in the valuation of the WTP across scenarios. In the whole sample, for home care, the mean WTP was €12.1/per month/per household for light care, €13.3 for medium care, and €14.7 for heavy care (p < .001). The mean WTP estimated with interval regressions had the same trend, with €15.7, €17.0, and €19.1 for light, medium, and heavy care respectively. For LCH, the mean WTP was €10.6 per month/household for light care, €14.7 for medium care, and €13.9 for heavy care. These differences too are significant (p < .001).
Table 3.
WTP Estimates on the whole sample and a sub-sample of “sure” respondents, according to scenario and preferred option
| Home care | Local health centre | |||||
|---|---|---|---|---|---|---|
| WTP /month/household | Scenario 1 (S1home) | Scenario 2 (S2home) | Scenario 3 (S3home) | Scenario 1 (S1LHC) | Scenario 2 (S2LHC) | Scenario 3 (S3LHC) |
| Full sample | n = 342 | n = 279 | n = 214 | n = 142 | n = 181 | n = 157 |
| mean (sd) a | 12.1 (13.3) | 13.3 (12.7) | 14.7 (16.0) | 10.6 (11.6) | 14.7 (26.4) | 13.9 (18.1) |
| median [IIQ] | 10.0 [3.0–20.0] | 10.0 [5.0–20.0] | 10.0 [5.0–25.0] | 8.0 [3.0–15.0] | 10.0 [5.0–20.0] | 10.0 [5.0–20.0] |
| intreg mean 95%IC b | 15.7 (12.6–20.1) | 17.0 (13.5–22.0) | 19.1 (14.2–26.7) | 13.92 (9.9–20.4) | 16.05 (12.2–21.9) | 17.6 (12.2–26.7) |
| intreg median 95% IC | 8.1 (7.1–9.2) | 9.8 (8.6–11.1) | 9.8 (8.4–11.5) | 7.3 (6.05–8.9) | 9.2 (7.8–10.7) | 8.7 (7.1–10.6) |
| Sure sample c | n = 243 | n = 202 | n = 163 | n = 95 | n = 125 | n = 115 |
| mean (sd) a | 13.2 (14.9) | 14.2 (13.8) | 15.8 (17.4) | 11.5 (13.1) | 13.1 (12.5) | 13.2 (13.9) |
| median [IIQ] | 10.0 [3.0–25.0] | 10 [5.0–25.0] | 15 [5.0–25.0] | 10.0 [3.0–20.0] | 10.0 [5.0–20.0] | 10.0 [5.0–20.0] |
| intreg mean 95%IC b | 17.3 (13.04–48.1) | 18.19 (13.8–25.1) | 20.3 (14.6–29.7) | 14.8 (9.9–23.8) | 17.1 (11.9–26.2) | 17.7 (11.4–29.5) |
| intreg median 95% IC | 8.3 (7.10–9.7) | 10.3 (8.9–12.0) | 10.6 (8.9–12.6) | 7.8 (6.2–9.7) | 9.0 (7.3–11.1) | 8.5 (6.7–10.8) |
| Unsure sample c | n = 99 | n = 77 | n = 51 | n = 47 | n = 56 | n = 42 |
| mean (sd) a | 9.55 (7.5) | 10.8 (8.9) | 11.1 (9.4) | 8.8 (7.4) | 12.8 (20.2) | 15.64 (26.5) |
| median [IIQ] | 10 [3.0–10.0] | 10 [5.0–15.0] | 10 [3.0–20.0] | 8 [3.0–10.0] | 9 [5.0–15.0] | 10 [5.0–15.0] |
| intreg mean 95%IC b | 12.5 (8.9–18.4) | 14.04 (9.4–22.4) | 15.1 (8.3–32.8) | 12.1 (6.7–26.2) | 14.0 (9.7–22.0) | 17.37 (9.4–38.9) |
| intreg median 95% IC | 7.6 (6.2–9.4) | 8.3 (6.6–10.6) | 7.8 (5.6–10.9) | 6.5 (4.6–9.2) | 9.4 (7.5–11.8) | 9.25 (6.5–13.1) |
WTP, willingness to pay.
This estimation considered that the respondent’s chosen amount on the PC is their true WTP, the WTP is estimated with a classical mean calculation.
The mean is estimated with a bootstrap replication of the interval regression which considers that the amount is an interval.
A respondent is considered sure if they have a score ≥7 on the VAS from 0 very uncertain to 10 very certain.
Finally, if we compare mean WTP between certain and uncertain respondents, the mean WTP was higher for respondents who were certain for all scenarios except for respondents who had a preference for LHC for heavy care whatever the method used. However, this difference is statistically significant only for respondents who had a preference for medium care at home (p = .035) and heavy care at home (p = .047). Analysis conducted among the “certain” respondents sample provided more or less the same results in terms of significant variables, but with different coefficients and a slightly better adjustment (R2 criteria) (Supplementary Material S4).
As shown in Table 4, household income (except in the sub-group of respondents who preferred LHC for heavy care) was a strong predictor of the WTP.
Table 4.
Interval regression analysis of WTP according to scenario and prefered option
| Scenario 1 Home | Scenario 1 LHC | Scenario 2 Home | Scenario 2 LHC | Scenario 3 Home | Scenario 3 LHC | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coef. | sd | pvalue | Coef. | Sd | pvalue | Coef. | Sd | pvalue | Coef. | Sd | pvalue | Coef. | Sd | pvalue | Coef. | Sd | pvalue | |
| Female sex (ref male) | —0.274* | 0.131 | .036 | —0.317 | 0.198 | .109 | —0.059 | 0.130 | .648 | —0.270 | 0.159 | .089 | —0.145 | 0.160 | .366 | −0.491* | 0.192 | .010 |
| Age (years) | —0.008 | 0.005 | .091 | —0.003 | 0.007 | .621 | —0.004 | 0.005 | .456 | 0.002 | 0.005 | .719 | 0.000 | 0.006 | .962 | −0.009 | 0.006 | .181 |
| Socio-professional category (ref: high) | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| Low | 0.420* | 0.171 | .014 | 0.326 | 0.261 | .212 | 0.215 | 0.164 | .188 | —0.110 | 0.215 | .611 | 0.380 | 0.198 | .055 | −0.233 | 0.263 | .376 |
| Inactive/Not employed | 0.255 | 0.165 | .122 | 0.376 | 0.252 | .137 | 0.260 | 0.163 | .111 | 0.056 | 0.206 | .787 | 0.175 | 0.206 | .394 | −0.023 | 0.256 | .928 |
| Annual household income (ref < €21.000) | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| €21,000 to < €36.000 | 0.401* | 0.177 | .024 | 0.493* | 0.246 | .046 | 0.352* | 0.173 | .042 | 0.183 | 0.211 | .386 | 0.482* | 0.207 | .020 | 0.016 | 0.250 | .950 |
| > €36,000 | 0.717*** | 0.195 | .000 | 0.752** | 0.263 | .004 | 0.650*** | 0.184 | .000 | 0.489* | 0.230 | .033 | 0.813*** | 0.222 | .000 | 0.241 | 0.290 | .406 |
| Missing | 0.774** | 0.287 | .007 | 0.779* | 0.383 | .042 | 0.578* | 0.281 | .040 | 0.422 | 0.296 | .154 | 0.978** | 0.340 | .004 | −0.124 | 0.384 | .746 |
| Perception of cancer risk (ref: High or very high) | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| Moderately high | 0.247 | 0.177 | .162 | 0.159 | 0.279 | .568 | 0.199 | 0.177 | .259 | 0.483* | 0.243 | .047 | 0.371 | 0.224 | .098 | 0.004 | 0.273 | .989 |
| Low or very low | 0.286 | 0.192 | .137 | 0.404 | 0.295 | .171 | 0.338 | 0.190 | .075 | 0.729** | 0.270 | .007 | 0.178 | 0.245 | .466 | 0.246 | 0.304 | .418 |
| Do not know | —0.077 | 0.185 | .678 | 0.785** | 0.277 | .005 | —0.038 | 0.177 | .829 | 0.855*** | 0.251 | .001 | —0.074 | 0.209 | .725 | 0.114 | 0.287 | .692 |
| Strength of preference VAS from 0 to 10 | 0.136** | 0.043 | .002 | —0.030 | 0.066 | .650 | 0.140*** | 0.042 | .001 | 0.130* | 0.059 | .027 | 0.101* | 0.051 | .049 | 0.196* | 0.076 | .010 |
| Degree of certainty VAS from 0 to 10 | —0.005 | 0.029 | .856 | 0.060 | 0.048 | .207 | —0.005 | 0.031 | .871 | —0.054 | 0.043 | .211 | 0.049 | 0.037 | .180 | −0.108* | 0.047 | .022 |
| Quality of Life (VAS from 0 to 10) | 0.090 | 0.047 | .055 | 0.135* | 0.060 | .023 | ||||||||||||
| Constant lnsigma | 0.679 | 0.457 | .138 | 1.016 | 0.613 | .097 | 0.669 | 0.427 | .117 | 0.818 | 0.566 | .148 | —0.373 | 0.605 | .538 | 0.998 | 0.737 | .176 |
| Constant | 0.085* | 0.041 | .037 | 0.034 | 0.064 | .598 | —0.012 | 0.045 | .785 | —0.025 | 0.055 | .647 | 0.035 | 0.052 | .495 | 0.071 | 0.061 | .239 |
| No. of cases | 342 | 142 | 279 | 181 | 214 | 157 | ||||||||||||
| AIC | 1,463 | 646 | 1,204 | 796 | 930 | 708 | ||||||||||||
| BIC | 1,517 | 687 | 1,255 | 841 | 980 | 754 | ||||||||||||
| Log likelihood | —718 | —309 | —588 | —384 | —450 | −339 | ||||||||||||
| R2 | 0.110 | 0.161 | 0.123 | 0.152 | 0.191 | 0.184 | ||||||||||||
| chi2 | 39.8* | 24.9* | 36.9*** | 29.8** | 45.5*** | 31.9** | ||||||||||||
VAS, visual analog scales; WTP, willingness to pay.
p < .05.
p < .01.
p < .001.
Whatever the scenario, for respondents who preferred home care, a higher strength of preference had a positive impact on valuation, whereas for LHC, this relation was not significant (p = .650).
Quality of life was a positive predictor of the WTP for S3home (p = .055) and S3LHC (p = .023) (S3, scenario for heavy care) but was not significant for other scenarios, the higher is the quality of life the higher is the WTP. Finally, education level, number of people in the household and experience of home care did not impact the mean WTP whatever the scenario was. The proportion of respondents who provided a zero valuation in response to the WTP questions ranged from 13.1 percent for scenarios 1 and 2 to 15 percent for scenario 3 (Supplementary Material S6). After the reclassification process, the rate of protest responses varied from 6.5 to 8.5 percent for scenarios 1 and 2 respectively.
Discussion
In this study, we elicited for the first time citizens’ preferences for home care, LHCs and hospital in the context of cancer management. We also assessed respondents’ WTP for their preferred option (home care or LHC) according to three different scenarios ranging from light cancer management to heavy (e.g., palliative) care.
Our results showed that the heavier the care scenarios were, the stronger were the preferences for hospital care. The mean WTP tendency also increased as the care scenario became heavier, that is, people were prepared to pay more for heavier care.
Concerning the acceptability and validity of the CV method, the proportions of protest responses and outliers were very low. Indeed, our proportion was never higher than 8.5 percent. A meta-analysis of 254 studies indicated that the rate of protest responses is around 18 percent on average, sometimes reaching 50 percent (31). Moreover, as expected, using the whole sample, the interval regression model indicated that income is a good predictor of the WTP. Additionally, the relation between WTP and strength of preference was significant and in the expected direction. These elements seem to confirm the validity of the CV survey results.
Concerning preferences, another French study (32) analyzed patient and population preferences for home care and hospital without focusing on a specific disease using the discrete choice experiment method. They found that 50 percent of patients and 50 percent of citizens preferred home care. The strength of their preference was also significantly higher for home care than for hospital whatever the scenario. We obtained similar results but the authors did not include LHC, which could explain a higher proportion of respondents who prefer home care. In a previous study about patients’ preferences, a large majority of patients preferred hospital (70 percent), a quarter preferred home care and only 5 percent LHC (10). This study showed that citizen’s preference are slightly different. Indeed, a large number of citizens preferred home care (between 30 and 46 percent depending on the scenario) or LHC (between 19 and 25 percent according to scenario). While the hospital is the preferred option for 35 to 49 percent of citizens depending on the scenario. We did not expect that patients and general public will have the same preferences. Our results confirms our expectation but enable us to quantify the differences in preferences for place of care (more details in Supplementary Material S5).
Limitations
Although the number of LHC has been increasing since the early 2010s, LHCs do not offer cancer care and people do not see them as potential place of care for cancer care. The LHC option may thus have been more subject to hypothetical bias and framing effect than the other options (33;34). The WTP question was only asked of respondents who declared they preferred home care or LHC. We decided to do so for two reasons: (i) WTP questions can both elicit option value and externalities or altruism value, that is, a respondent who prefers hospital could be willing to pay for the development of home care or LHC for others. We chose to isolate the altruism value because this value could generate a “warm glow” effect (social desirability bias) (35). We could have asked a WTA question to give us the preferred option of all respondents who preferred hospital too, but WTA is known to suffer from a bias due to the lack of budget constraint and to loss aversion (36).
Additionally, we used a payment card (PC) because it is the most common elicitation format in health surveys (37). Although PCs can suffer from range and central value bias, we chose not to present the amount randomly as suggested by some authors (38). Indeed, random payment cards can increase cognitive burden (39). Moreover, there is no strong evidence that random PCs avoid this bias and we thought that randomizing the PC might decrease the credibility of the WTP questions (40).
Finally, the order of the WTP questions could influence the mean WTP, even though we stressed that the three WTP questions would be asked depending on the individual’s preferences (41;42). However, the fact that the differences between WTPs across scenarios were significant could indicate that respondents considered each scenario independently of their order.
Strengths
We measured citizens’ strength of preferences using two methods, that is, VAS, but since they do not allow to take into account the opportunity costs (i.e., how much an individual is willing to give up to benefit from a service or a good in case it requires additional resources to implement), we decided to add the WTP measure. This method could help health policy DMs to determine if the development of new modalities of care represents a good use of scarce resources (e.g., use them in a cost-benefit analysis).
Health policy DMs are claiming, without any rigorous evidence that, LHC and HC are cheaper than hospital care. This seems to be their main reason to develop them. If this is not the case than the additional resources to develop these options for care will have to come from somewhere (i.e., one has to consider the opportunity cost of investing in LHC and HC for cancer care instead of other potential uses of these resources). Using the WTP approach our study shows how to estimate the total WTP of the population for such services.
We chose to use a direct measure of WTP (as suggested in CV studies) and not a Discrete Choice Experiment (DCE) for several reasons. In DCE, alternatives are described based on their attributes (characteristics of the alternatives) and levels that are modified in different scenarios. Cost could be considered as an attribute and thus an indirect WTP could be assessed. Even if some authors argue that WTP in DCE survey is less sensitive to strategic or protest bias (43), some others emphasize that cost attribute could be neglected or even ignored by respondents in favor of other attributes (44–46), thus leading DCE to provide a biased WTP. To our knowledge, there is no evidence showing the superiority of DCE to CV in WTP estimation. In addition, our study was part of a larger study that used a decision aid (DA) that provided realistic alternatives (options), it made sense to use a direct measurement of WTP which is based on the use of a DA as an important component. To use a DCE to measure WTP would have required to add a new study.
Conclusion
Although the CV method is more widely used (12;47–49), a large number of CV surveys have been used to elicit only patient preferences. We thus decided to conduct a CV survey among the general population, to answer the question about their prospective preferences for a place of care for a serious disease such as cancer. We have conducted a similar study among cancer patients sample of this same region. We realized that cancer patients’ preferences might differ from those of the public. Each of these groups preferences have a role in policy decisions re services. The WTP of the public (e.g., via additional taxation) gave us indication re what services will be funded. Patients’ preferences gave us idea re how likely are these services to be demanded.
There is a mismatch between what DM think will happen and what both of our studies showed. DM must work to converge both patients and general public’ preferences and better inform them about benefits and risks of each possible options including alternatives (LHC and home care) to hospital.
Acknowledgment
We thank Louisa Blair for the comments that greatly improved the translation of the manuscript.
Supplementary material
For supplementary material accompanying this paper visit https://doi.org/10.1017/S0266462322000599.
click here to view supplementary material
Funding statement
This work was granted by French National League Against Cancer (grant numbers not applicable).
Conflicts of interest
The authors declare none.
References
- 1.World Health Organisation. [Internet] Cancer. [cited 2020 Nov 19]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.
- 2.HAS. Conditions du développement de la chimiothérapie en hospitalisation à domicile : analyse économique et organisationnelle. HAS/Service évaluation économique et santé publique. 2015 Jan.
- 3.Corbett M, Heirs M, Rose M, et al. The delivery of chemotherapy at home: An evidence synthesis [Internet]. Southampton, UK: NIHR Journals Library; [cited 2018 Nov 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285513/. [PubMed] [Google Scholar]
- 4.Leff B, Burton L, Mader S, et al. Satisfaction with hospital at home care. J Am Geriat Soc. 2006;54:1355–1363. [DOI] [PubMed] [Google Scholar]
- 5.IGAS. Hospitalisation à domicile (HAD). Inspection générale des affaires sociales IGAS; 2010 Nov. Report No.: RM2010-109P.
- 6.Buthion V. DOveHO : Structures de proximité versus plateaux techniques en cancérologie [Internet]. Université Lumière Lyon 2; Université Claude Bernard Lyon 1; [cited 2017 Sep 25]. Available from: https://hal.archives-ouvertes.fr/hal-01133371.
- 7.Shepperd S, Gonçalves-Bradley DC, Straus SE, Wee B. Hospital at home: Home-based end-of-life care. Cochrane Database Syst Rev. 2016;2:CD009231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lüthi F, Fucina N, Divorne N, et al. Home care--A safe and attractive alternative to inpatient administration of intensive chemotherapies. Support Care Cancer. 2012; 20:575–581. [DOI] [PubMed] [Google Scholar]
- 9.HAS. Haute Autorité de Santé - Chimiothérapie en hospitalisation à domicile : une pratique à développer. [cited 2017 Sep 25]. Available from: www.has-sante.fr; https://has-sante.fr/jcms/pprd_2974354/en/chimiotherapie-en-hospitalisation-a-domicile-une-pratique-a-developper.
- 10.Margier J, Gafni A, Moumjid N. Cancer care at home or in local health centres versus in hospital: Public policy goals and patients’ preferences in the Rhône-Alps region in France. Health Policy. 2021; 125:213–220. [DOI] [PubMed] [Google Scholar]
- 11.Donaldson C. Eliciting patients’ values by use of ‘willingness to pay’: Letting the theory drive the method. Health Expect. 2001; 4:180–188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Smith RD, Sach TH. Contingent valuation: What needs to be done? Health Econ Policy Law. 2010; 5:91. [DOI] [PubMed] [Google Scholar]
- 13.Smith RD. Contingent valuation in health care: Does it matter how the “good” is described? Health Econ. 2008;17:607–617. [DOI] [PubMed] [Google Scholar]
- 14.Syrowatka A, Krömker D, Meguerditchian AN, Tamblyn R. Features of computer-based decision aids: Systematic review, thematic synthesis, and meta-analyses. J Med Internet Res. 2016;18:e20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Elwyn G, O’Connor A, Stacey D, et al. International patient decision aids standards (IPDAS) collaboration. Developing a quality criteria framework for patient decision aid: Online international Delphi consensus process. Br Med J. 2006;333:417–419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Cummings RG, Brookshire DS, Bishop RC, Arrow KJ. Valuing environmental goods: An assessment of the contingent valuation method. Rowman & Littlefield Pub Incorporated. 1986.
- 17.Aadland D, Caplan AJ. Willingness to pay for curbside recycling with detection and mitigation of hypothetical bias. Am J Agric Econ. 2003;85:492–502. [Google Scholar]
- 18.List JA, Gallet CA. What experimental protocol influence disparities between actual and hypothetical stated values? Environ Resour Econ. 2001;20(3):241–254. [Google Scholar]
- 19.Lusk JL. Effects of cheap talk on consumer willingness-to-pay for golden rice. Am J Agric Econ. 2003;85:840–856. [Google Scholar]
- 20.Bateman IJ, Covey J, Loomes G. Valuing risk reductions: Testing for range biases in payment card and random card sorting methods. CSERGE Working Paper EDM. [cited 2015 Aug 6]. Available from: http://www.econstor.eu/handle/10419/80296.
- 21.Gyrd-Hansen D, Jensen ML, Kjaer T. Framing the willingness-to-pay question: Impact on response patterns and mean willingness to pay. Health Econ. 2014;23:550–563. [DOI] [PubMed] [Google Scholar]
- 22.Morrison MD, Blamey RK, Bennett JW. Minimising payment vehicle bias in contingent valuation studies. Environ Resour Econ. 2000;16:407–422. [Google Scholar]
- 23.Mitchell RC, Carson RT. Using surveys to value public goods: The contingent valuation method. Resources for the Future. Washington, D.C.: Routledge; 1989, p. 496. [Google Scholar]
- 24.Champ PA, Bishop RC, Brown TC, McCollum DW. Using donation mechanisms to value nonuse benefits from public goods. J Environ Econ Manag. 1997;33:151–162. [Google Scholar]
- 25.Mitchell RC, Carson RT. An experiment in determining willingness to pay for national water quality improvements. In: Draft report to the US Environmental Protection Agency. Washington, DC: US Environmental Protection Agency; 1981. [Google Scholar]
- 26.Hanemann WM. Welfare evaluations in contingent valuation experiments with discrete responses. Am J Agric Econ. 1984;66:332–341. [Google Scholar]
- 27.Mahieu PA, Riera P, Giergiczny M. Determinants of willingness-to-pay for water pollution abatement: A point and interval data payment card application. J Environ Manage. 2012;108:49–53. [DOI] [PubMed] [Google Scholar]
- 28.Ethier RG, Poe GL, Schulze WD, Clark J. A comparison of hypothetical phone and mail contingent valuation responses for green-pricing electricity programs. Land Econ. 2000;76:54–67. [Google Scholar]
- 29.Poe GL, Clark JE, Rondeau D, Schulze WD. Provision point mechanisms and field validity tests of contingent valuation. Environ Resour Econ. 2002;23:105–131. [Google Scholar]
- 30.Freeman AM. The measurement of environmental and resource values: Theory and methods. Resources for the Future. New York: Routledge; 1992. [cited 2017 Oct 7] Available from: http://www.sidalc.net/cgi-bin/wxis.exe/?IsisScript=iicacr.xis&method=post&formato=2&cantidad=1&expresion=mfn=029160. [Google Scholar]
- 31.Meyerhoff J, Liebe U. Determinants of protest responses in environmental valuation: A meta-study. Ecol Econ. 2010;70:366–374. [Google Scholar]
- 32.Blayac T, Clément V, Mercier G. Hospitalisation conventionnelle vs prise en charge à domicile: Analyse des préférences individuelles par une expérience en choix discret. [cited 2017 Sep 11] Available from: http://www.lameta.univ-montp1.fr/Documents/DR2014-14.pdf.
- 33.Alberini A, Boyle K, Welsh M. Analysis of contingent valuation data with multiple bids and response options allowing respondents to express uncertainty. J Environ Econ Manag. 2003;45:40–62. [Google Scholar]
- 34.Corso PS, Hammitt JK, Graham JD. Valuing mortality-risk reduction: Using visual aids to improve the validity of contingent valuation. J Risk Uncertain. 2001;23:165–184. [Google Scholar]
- 35.Andreoni J. Impure altruism and donations to public goods: A theory of warm-glow giving. Econ J. 1990;100:464–477. [Google Scholar]
- 36.Kahneman D, Tversky A. Choices, values, and frames. Am Psychol. 1984;39:341. [Google Scholar]
- 37.Smith RD. It’s not just what you do, it’s the way that you do it: The effect of different payment card formats and survey administration on willingness to pay for health gain. Health Econ. 2006;15:281–293. [DOI] [PubMed] [Google Scholar]
- 38.Voltaire L, Donfouet HPP, Pirrone C. Testing for payment card framing effect on contingent willingness to pay [cited 2015 Aug 6]. Available from: http://www.researchgate.net/profile/Louinord_Voltaire/publication/275098480_Testing_for_Payment_Card_Framing_effect_on_Contingent_Willingness_to_Pay/links/553278980cf20ea0a073dcce.pdf.
- 39.Andersen S, Harrison GW, Lau MI, Rutström EE. Elicitation using multiple price list formats. Exp Econ. 2006;9:383–405. [Google Scholar]
- 40.Voltaire L, Donfouet HPP, Pirrone C, Larzillière A. Respondent uncertainty and ordering effect on willingness to pay for salt marsh conservation in the brest roadstead (France). Ecol Econ. 2017; 137:47–55. [Google Scholar]
- 41.Anderson KG, Brackenbury L, Quackenbush M, Buras M, Brown SA, A-SIDE Price J.: Video simulation of teen alcohol and marijuana use contexts. J Stud Alcohol Drugs. 2014; 75:953–957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bateman IJ, Cole M, Cooper P, et al. On visible choice sets and scope sensitivity. J Environ Econ Manag. 2004;47:71–93. [Google Scholar]
- 43.Ryan M, Watson V. Comparing welfare estimates from payment card contingent valuation and discrete choice experiments. Health Econ. 2009;18:389–401. [DOI] [PubMed] [Google Scholar]
- 44.Bijlenga D, Bonsel GJ, Birnie E. Eliciting willingness to pay in obstetrics: Comparing a direct and an indirect valuation method for complex health outcomes. Health Econ. 2011;20:1392–1406. [DOI] [PubMed] [Google Scholar]
- 45.Chapman GB. Your money or your health: Time preferences and trading money for health. Med Decis Making. 2002; 22:410–416. [DOI] [PubMed] [Google Scholar]
- 46.Sever I, Verbič M, Sever EK. Estimating willingness-to-pay for health care: A discrete choice experiment accounting for non-attendance to the cost attribute. J Eval Clin Pract. 2019; 25:843–849. [DOI] [PubMed] [Google Scholar]
- 47.Baker R, Currie GR, Donaldson C. What needs to be done in contingent valuation: have Smith and Sach missed the boat? Health Econ Policy Law. 2010; 5:113. [DOI] [PubMed] [Google Scholar]
- 48.Smith RD, Sach TH. Contingent valuation: has the debate begun? Health Econ Policy Law. 2010; 5:133. [DOI] [PubMed] [Google Scholar]
- 49.Smith RD, Sach TH. Contingent valuation: (Still) on the road to nowhere? Health Econ. 2009; 18:863–866. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
For supplementary material accompanying this paper visit https://doi.org/10.1017/S0266462322000599.
click here to view supplementary material

